We are proud to announce that Helfie AI has been named a finalist in the 2025 Prix Galien USA Awards (Read announcement here) in the category of Best Digital Health Solution, a global recognition often described as the “Nobel Prize for biopharmaceutical research and digital health innovation.”
The Prix Galien Awards honor extraordinary scientific innovation that improves the human condition. This year’s winners will be announced at the prestigious Prix Galien USA Awards Ceremony on October 30, 2025, at the American Museum of Natural History in New York City.
An independent jury of renowned scientists, industry leaders, and Nobel Laureates reviews hundreds of entries from around the world to identify those with the greatest potential to transform healthcare.
Thank you to our team, partners, supporters and investors who share our vision and believe in the work that we are doing.
Our Mission: Preventative Health Intelligence for All
Helfie AI resets the trajectory of health by pairing everyone with their own health AI; checking key conditions, delivering intelligent insights, and enabling persistent monitoring, all via mobile within seconds and for cents.
Helfie AI is designed to address some of the world’s most significant health challenges; conditions that drive global morbidity and preventable mortality.
Our platform delivers condition-specific AI health checks and proactive monitoring tools for over 20 areas of health, including cardiovascular wellness, respiratory function, High risk skin lesion detection, STIs, and more coming soon.
Our vision is bold yet simple:
If every person on Earth could actively participate in preventative healthcare, we could change the trajectory of human life. By turning a smartphone into a powerful personal health companion, Helfie AI enables early detection, timely intervention, and equitable access to care, regardless of geography, income, or infrastructure.
Imagine a future where diseases are caught early, treatments are more effective, and healthcare spending shifts from expensive treatments to cost-effective prevention.
That future is Helfie.
0 comments